GERMXIT® GEL & LIQUID GERMXIT ANTIBACTERIAL AND ...

GERMXIT® GEL & LIQUID GERMXIT ANTIBACTERIAL AND ANTIFUNGAL EFFICIENCY TESTS.

Over the course of 20 years GermXit® has been tested and Proved positive against all of the following organisms in this complete report with the new findings of tests against

Influenza A, Influenza B and Human Corona Virus :

Bacteria:

S. aureus ATCC 6538 (Mahidol University, 2015)

S. choleraesuis ATCC 10708 (Mahidol University, 2015)

E. coli ATCC 25922 (Monash University, 2002)

E. coli ATCC 10536 (PSB Corporation, Singapore, 2003)

Staphylococcus aureus ATCC 6538 (PSB Corporation, Singapore, 2003)

Pseudomonas aeruginosa ATCC 15422 (PSB Corporation, Singapore, 2003)

Salmonella typhimurium ATCC 14028 (PSB Corporation, Singapore, 2003)

Salmonella Salford

Legionella pneumophila ATCC 33152 (PSB Corporation, Singapore, 2003)

Total bacterial plate counts, including Legionella species bacteria (Micro Tech Laboratories, Victoria, 2000)

B. Anthracis (under specific conditions) (Agriculture Victorian Institute of Animal Science, Australia, 2001)

Proteus vulgaris, Serratia marcescens, Enterococcus faecalis, Enterohacter aerogenes. Coryncbacterum sp Propionebacter, Pseudomonus putido, Staphylococcus epidermidis, Staphylocccus aureus, Bacillus subtilis, Bacillus cerus, Micrococcus Iuteus (Monash University, Australia)

Fungi: Aspergillus Niger

T. mentagrophytes

Candida albicans ATCC 2091

These tests were conducted both under laboratory, as well as field conditions.

GERMXIT®: VIRUCIDAL ACTIVITIES TESTS

Message from the laboratory:

“…We thank you for giving us this opportunity to test two of your products for virucidal activities, adding to your list of bactericidal and fungicidal tests conducted. With a full report on European Standard EN14476 (passing all 3 obligatory viruses) on GermXit Liquid, you could open market doors using this product of yours (as ingredient for surface virus disinfectant).

Perhaps we could work together again in the future if you would like to add claims or register new products in Europe. According to the CEN-CENELEC Internal Regulations, the national standards organizations of the following countries are bound to implement this European Standard: Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, Former Yugoslav Republic of Macedonia, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey and the United Kingdom.

We look forward to hear from you of new products in the pipeline that could help reduce infections in both hospitals and homes.

Regards,

Dr Peter Cheong Head of Microbiological Testing”

May 5th, 2020

GermXit® Liquid has successfully passed the tests against:

• Human Coronavirus

• Influenza A

GermXit® Gel has successfully passed the tests against:

• Influenza A (H1N1), strain A/Swine/1976/31, ATCC VR-1682

• Influenza B, strain B/Hong Kong/5/72, ATCC VR-823

Details of tests, conducted by Viroxy Sdn. Bhd., between April 17-29, 2020, are quoted below.

DETERMINATION OF THE VIRUCIDAL ACTIVITY (EN 14476) OF GERMXIT LIQUID

Conclusion

GermXit Liquid showed the required virus reduction of ≥4.0 log10 against test strains Human

coronavirus ATCC VR-740 and Influenza A (H1N1) ATCC VR-1682 in accordance with EN

14476:2013+A1:2015 (E) at 100.00 %* concentration after 60 minutes under the stated condition.

According to the simple acceptance decision rule†, there is a minimal risk of false acceptance.

Lab No.: VX-59-20-0002

Sample Name: GermXit Liquid

Method: EN 14476:2013+A1:2015 (E)

Sample name: GermXit Liquid

Batch no.: 2020-03-09-B

Sample Receipt Date: 12 March 2020

Report Date: 23 April 2020

Active substances:

5.00 % Tea tree oil 6.00 % Ethanol

Test organism(s):

• Human coronavirus, strain 229E, ATCC

VR-740

• Influenza A (H1N1), strain

A/Swine/1976/31, ATCC VR-1682

Concentration/contact time: 100.00 %* / 60

minutes

Loading: 3.00 g/L bovine albumin solution

HUMAN CORONAVIRUS

INFLUENZA A (H1N1)

DETERMINATION OF THE VIRUCIDAL ACTIVITY (EN 14476) OF GERMXIT GEL

Lab No.: VX-59-20-0001

Sample Name: GermXit Gel

Method: EN 14476:2013+A1:2015 (E)

Sample Receipt Date: 12 March 2020

Report Date: 4 May 2020

Sample name: GermXit Gel

Batch no.: 2020-03-09A

Active substances per 100 g:

10.00 % pure Tea Tree Oil

Test organism(s):

• Influenza A (H1N1), strain

A/Swine/1976/31, ATCC VR-1682

• Influenza B, strain B/Hong Kong/5/72,

ATCC VR-823

Concentration/contact time: 100.00 %* / 60

minutes

Loading: 3.0 g/L bovine albumin solution

Conclusion GermXit Gel showed the required virus reduction of ≥4.0 log10 against test strains Influenza A (H1N1)

ATCC VR-1682 and Influenza B ATCC VR-823 in accordance with EN 14476:2013+A1:2015 (E) at 100.00

%* concentration after 60 minutes under the stated condition. According to the simple acceptance

decision rule†, there is less than 50 % risk of false acceptance for Influenza A (H1N1) ATCC VR-1682,

and a minimal risk of false acceptance for Influenza B ATCC VR-823.

INFLUENZA A (H1N1)

INFLUENZA B